PDF herunterladen
Semin Neurol 2020; 40(06): 595-605
DOI: 10.1055/s-0040-1719075
Review Article

Acute Provoked Seizures—Work-Up and Management in Adults

Rana Moosavi
1   Department of Neurology, Duke University Medical Center, Durham, North Carolina
,
Christa B. Swisher
1   Department of Neurology, Duke University Medical Center, Durham, North Carolina
› Institutsangaben
› Weitere Informationen
    Lizenzen und Reprints

Abstract

Acute provoked seizures, also known as acute symptomatic seizures, occur secondary to a neurological or systemic precipitant, commonly presenting as a first-time seizure. In this article, we will discuss etiology, emergent protocols, medical work-up, initial treatment, and management of these seizures. The definitions, classifications, and management of convulsive status epilepticus and nonconvulsive status epilepticus in an acute setting will also be reviewed.

Keywords

acute provoked seizures - acute symptomatic seizures - nonconvulsive seizures - convulsive status epilepticus


Publikationsverlauf

Artikel online veröffentlicht:
05. November 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Beleza P. Acute symptomatic seizures: a clinically oriented review. Neurologist 2012; 18 (03) 109-119
    CrossrefPubMedGoogle Scholar
  • 2 Beghi E, Carpio A, Forsgren L. et al. Recommendation for a definition of acute symptomatic seizure. Epilepsia 2010; 51 (04) 671-675
    CrossrefPubMedGoogle Scholar
  • 3 Karceski S. Acute symptomatic seizures and systemic illness. Continuum (Minneap Minn) 2014; 20 (3 Neurology of Systemic Disease): 614-623
    PubMedGoogle Scholar
  • 4 Fisher RS, Cross JH, French JA. et al. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017; 58 (04) 522-530
    CrossrefPubMedGoogle Scholar
  • 5 Husain AM, Horn GJ, Jacobson MP. Non-convulsive status epilepticus: usefulness of clinical features in selecting patients for urgent EEG. J Neurol Neurosurg Psychiatry 2003; 74 (02) 189-191
    CrossrefPubMedGoogle Scholar
  • 6 Chong DJ, Hirsch LJ. Which EEG patterns warrant treatment in the critically ill? Reviewing the evidence for treatment of periodic epileptiform discharges and related patterns. J Clin Neurophysiol 2005; 22 (02) 79-91
    CrossrefPubMedGoogle Scholar
  • 7 Brophy GM, Bell R, Claassen J. Neurocritical Care Society Status Epilepticus Guideline Writing Committee. et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012; 17 (01) 3-23
    CrossrefPubMedGoogle Scholar
  • 8 Trinka E, Cock H, Hesdorffer D. et al. A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia 2015; 56 (10) 1515-1523
    CrossrefPubMedGoogle Scholar
  • 9 Nelson SE, Varelas PN. Status epilepticus, refractory status epilepticus, and super-refractory status epilepticus. Continuum (Minneap Minn) 2018; 24 (06) 1683-1707
    PubMedGoogle Scholar
  • 10 Beniczky S, Hirsch LJ, Kaplan PW. et al. Unified EEG terminology and criteria for nonconvulsive status epilepticus. Epilepsia 2013; 54 (Suppl. 06) 28-29
    CrossrefPubMedGoogle Scholar
  • 11 Annegers JF, Hauser WA, Lee JR-J, Rocca WA. Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935-1984. Epilepsia 1995; 36 (04) 327-333
    CrossrefPubMedGoogle Scholar
  • 12 Hesdorffer DC, D'Amelio M. Mortality in the first 30 days following incident acute symptomatic seizures. Epilepsia 2005; 46 (Suppl. 11) 43-45
    CrossrefPubMedGoogle Scholar
  • 13 Hesdorffer DC, Benn EKT, Cascino GD, Hauser WA. Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure. Epilepsia 2009; 50 (05) 1102-1108
    CrossrefPubMedGoogle Scholar
  • 14 Holmquist L. Hospitalizations for Epilepsy and Convulsions, 2005. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs #46 [Internet]. 2008 . Available at: https://www.ncbi.nlm.nih.gov/books/NBK56315/. Accessed September 4, 2019
    PubMedGoogle Scholar
  • 15 Fields MC, Labovitz DL, French JA. Hospital-onset seizures: an inpatient study. JAMA Neurol 2013; 70 (03) 360-364
    CrossrefPubMedGoogle Scholar
  • 16 Oddo M, Carrera E, Claassen J, Mayer SA, Hirsch LJ. Continuous electroencephalography in the medical intensive care unit. Crit Care Med 2009; 37 (06) 2051-2056
    CrossrefPubMedGoogle Scholar
  • 17 Claassen J, Mayer SA, Kowalski RG, Emerson RG, Hirsch LJ. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology 2004; 62 (10) 1743-1748
    CrossrefPubMedGoogle Scholar
  • 18 Wasim M, Husain AM. Nonconvulsive seizure control in the intensive care unit. Curr Treat Options Neurol 2015; 17 (03) 340
    CrossrefPubMedGoogle Scholar
  • 19 Zehtabchi S, Abdel Baki SG, Malhotra S, Grant AC. Nonconvulsive seizures in patients presenting with altered mental status: an evidence-based review. Epilepsy Behav 2011; 22 (02) 139-143
    CrossrefPubMedGoogle Scholar
  • 20 Naeije G, Depondt C, Meeus C, Korpak K, Pepersack T, Legros B. EEG patterns compatible with nonconvulsive status epilepticus are common in elderly patients with delirium: a prospective study with continuous EEG monitoring. Epilepsy Behav 2014; 36: 18-21
    CrossrefPubMedGoogle Scholar
  • 21 Jette N, Claassen J, Emerson RG, Hirsch LJ. Frequency and predictors of nonconvulsive seizures during continuous electroencephalographic monitoring in critically ill children. Arch Neurol 2006; 63 (12) 1750-1755
    CrossrefPubMedGoogle Scholar
  • 22 Friedman D, Claassen J, Hirsch LJ. Continuous electroencephalogram monitoring in the intensive care unit. Anesth Analg 2009; 109 (02) 506-523
    CrossrefPubMedGoogle Scholar
  • 23 Camilo O, Goldstein LB. Seizures and epilepsy after ischemic stroke. Stroke 2004; 35 (07) 1769-1775
    CrossrefPubMedGoogle Scholar
  • 24 Beghi E, D'Alessandro R, Beretta S. Epistroke Group. et al. Incidence and predictors of acute symptomatic seizures after stroke. Neurology 2011; 77 (20) 1785-1793
    CrossrefPubMedGoogle Scholar
  • 25 Gunawardane N, Fields M. Acute symptomatic seizures and provoked seizures: to treat or not to treat?. Curr Treat Options Neurol 2018; 20 (10) 41
    CrossrefPubMedGoogle Scholar
  • 26 McLauchlan DJ, Powell R. Acute symptomatic seizures. Pract Neurol 2012; 12 (03) 154-165
    CrossrefPubMedGoogle Scholar
  • 27 Bladin CF, Alexandrov AV, Bellavance A. et al. Seizures after stroke: a prospective multicenter study. Arch Neurol 2000; 57 (11) 1617-1622
    CrossrefPubMedGoogle Scholar
  • 28 Claassen J, Peery S, Kreiter KT. et al. Predictors and clinical impact of epilepsy after subarachnoid hemorrhage. Neurology 2003; 60 (02) 208-214
    CrossrefPubMedGoogle Scholar
  • 29 Dastur CK, Yu W. Current management of spontaneous intracerebral haemorrhage. Stroke Vasc Neurol 2017; 2 (01) 21-29
    CrossrefPubMedGoogle Scholar
  • 30 Won S-Y, Konczalla J, Dubinski D. et al. A systematic review of epileptic seizures in adults with subdural haematomas. Seizure 2017; 45: 28-35
    CrossrefPubMedGoogle Scholar
  • 31 Hillbom M, Pieninkeroinen I, Leone M. Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management. CNS Drugs 2003; 17 (14) 1013-1030
    CrossrefPubMedGoogle Scholar
  • 32 Nwani PO, Nwosu MC, Nwosu MN. Epidemiology of acute symptomatic seizures among adult medical admissions. Epilepsy Res Treat 2016; 2016: 4718372
    PubMedGoogle Scholar
  • 33 Kim MA, Park KM, Kim SE, Oh MK. Acute symptomatic seizures in CNS infection. Eur J Neurol 2008; 15 (01) 38-41
    CrossrefPubMedGoogle Scholar
  • 34 Zoons E, Weisfelt M, de Gans J. et al. Seizures in adults with bacterial meningitis. Neurology 2008; 70 (22) (Pt 2): 2109-2115
    CrossrefPubMedGoogle Scholar
  • 35 Rosman NP, Peterson DB, Kaye EM, Colton T. Seizures in bacterial meningitis: prevalence, patterns, pathogenesis, and prognosis. Pediatr Neurol 1985; 1 (05) 278-285
    CrossrefPubMedGoogle Scholar
  • 36 Annegers JF, Hauser WA, Beghi E, Nicolosi A, Kurland LT. The risk of unprovoked seizures after encephalitis and meningitis. Neurology 1988; 38 (09) 1407-1410
    CrossrefPubMedGoogle Scholar
  • 37 Singhi P. Neurocysticercosis. Ther Adv Neurol Disord 2011; 4 (02) 67-81
    CrossrefPubMedGoogle Scholar
  • 38 Joseph FG, Scolding NJ. Cerebral vasculitis: a practical approach. Pract Neurol 2002; 2 (02) 80-93
    CrossrefPubMedGoogle Scholar
  • 39 Dalmau J, Gleichman AJ, Hughes EG. et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7 (12) 1091-1098
    CrossrefPubMedGoogle Scholar
  • 40 Riggs JE. Neurologic manifestations of electrolyte disturbances. Neurol Clin 2002; 20 (01) 227-239 , vii
    CrossrefPubMedGoogle Scholar
  • 41 Glauser T, Shinnar S, Gloss D. et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr 2016; 16 (01) 48-61
    CrossrefPubMedGoogle Scholar
  • 42 Claassen J, Goldstein JN. Emergency neurological life support: status epilepticus. Neurocrit Care 2017; 27 (Suppl. 01) 152-158
    CrossrefPubMedGoogle Scholar
  • 43 Litt B, Wityk RJ, Hertz SH. et al. Nonconvulsive status epilepticus in the critically ill elderly. Epilepsia 1998; 39 (11) 1194-1202
    CrossrefPubMedGoogle Scholar
  • 44 Abend NS, Dlugos DJ, Hahn CD, Hirsch LJ, Herman ST. Use of EEG monitoring and management of non-convulsive seizures in critically ill patients: a survey of neurologists. Neurocrit Care 2010; 12 (03) 382-389
    CrossrefPubMedGoogle Scholar
  • 45 Kowalski RG, Ziai WC, Rees RN. et al. Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation. Crit Care Med 2012; 40 (09) 2677-2684
    CrossrefPubMedGoogle Scholar
  • 46 Sutter R, Marsch S, Fuhr P, Kaplan PW, Rüegg S. Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. Neurology 2014; 82 (08) 656-664
    CrossrefPubMedGoogle Scholar
  • 47 Alvarez V, Lee JW, Westover MB. et al. Therapeutic coma for status epilepticus: differing practices in a prospective multicenter study. Neurology 2016; 87 (16) 1650-1659
    CrossrefPubMedGoogle Scholar
  • 48 Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002; 59 (02) 205-210
    CrossrefPubMedGoogle Scholar
  • 49 Treiman DM, Meyers PD, Walton NY. Veterans Affairs Status Epilepticus Cooperative Study Group. et al. A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med 1998; 339 (12) 792-798
    CrossrefPubMedGoogle Scholar
  • 50 Alldredge BK, Gelb AM, Isaacs SM. et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001; 345 (09) 631-637
    CrossrefPubMedGoogle Scholar
  • 51 Rao SK, Mahulikar A, Ibrahim M, Shah A, Seraji-Bozorgzad N, Mohamed W. Inadequate benzodiazepine dosing may result in progression to refractory and non-convulsive status epilepticus. Epileptic Disord 2018; 20 (04) 265-269
    CrossrefPubMedGoogle Scholar
  • 52 Silbergleit R, Durkalski V, Lowenstein D. NETT Investigators. et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012; 366 (07) 591-600
    CrossrefPubMedGoogle Scholar
  • 53 Husain AM, Lee JW, Kolls BJ. Critical Care EEG Monitoring Research Consortium. et al. Randomized trial of lacosamide versus fosphenytoin for nonconvulsive seizures. Ann Neurol 2018; 83 (06) 1174-1185
    CrossrefPubMedGoogle Scholar
  • 54 Brigo F, Del Giovane C, Nardone R, Trinka E, Lattanzi S. Intravenous antiepileptic drugs in adults with benzodiazepine-resistant convulsive status epilepticus: A systematic review and network meta-analysis. Epilepsy Behav 2019; 101 (Pt B): 106466
    CrossrefPubMedGoogle Scholar
  • 55 French JA, Gazzola DM. Antiepileptic drug treatment: new drugs and new strategies. Continuum (Minneap Minn) 2013; 19 (3 Epilepsy): 643-655
    PubMedGoogle Scholar
  • 56 Yasiry Z, Shorvon SD. The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies. Seizure 2014; 23 (03) 167-174
    CrossrefPubMedGoogle Scholar
  • 57 Falip M, Carreño M, Amaro S. et al. Use of levetiracetam in hospitalized patients. Epilepsia 2006; 47 (12) 2186-2188
    CrossrefPubMedGoogle Scholar
  • 58 Höfler J, Trinka E. Lacosamide as a new treatment option in status epilepticus. Epilepsia 2013; 54 (03) 393-404
    CrossrefPubMedGoogle Scholar
  • 59 Abou-Khalil BW. Update on antiepileptic drugs 2019. Continuum (Minneap Minn) 2019; 25 (02) 508-536
    PubMedGoogle Scholar
  • 60 Hocker S, Clark S, Britton J. Parenteral phenobarbital in status epilepticus revisited: Mayo Clinic experience. Epilepsia 2018; 59 (Suppl. 02) 193-197
    CrossrefPubMedGoogle Scholar
  • 61 Ho C-J, Lin C-H, Lu Y-T. et al. Perampanel treatment for refractory status epilepticus in a neurological intensive care unit. Neurocrit Care 2019; 31 (01) 24-29
    CrossrefPubMedGoogle Scholar
  • 62 Leo A, Giovannini G, Russo E, Meletti S. The role of AMPA receptors and their antagonists in status epilepticus. Epilepsia 2018; 59 (06) 1098-1108
    CrossrefPubMedGoogle Scholar
  • 63 Klein P, Schiemann J, Sperling MR. et al. A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures. Epilepsia 2015; 56 (12) 1890-1898
    CrossrefPubMedGoogle Scholar
  • 64 Farrokh S, Bon J, Erdman M, Tesoro E. Use of newer anticonvulsants for the treatment of status epilepticus. Pharmacotherapy 2019; 39 (03) 297-316
    CrossrefPubMedGoogle Scholar
  • 65 Ng Y-T, Collins SD. Clobazam. Neurotherapeutics 2007; 4 (01) 138-144
    CrossrefPubMedGoogle Scholar